Module

Update on Managing Methamphetamine Abuse in the Setting of HIV Infection

Source: HIV/AIDS Annual Update 2009

Update on Managing Methamphetamine Abuse in the Setting of HIV Infection

Program Chair: Kimberly Y. Smith, MD, MPH

Faculty:

Steven Shoptaw, PhD

CREDIT INFORMATION

Release Date: May 28, 2009

Expiration Date: May 27, 2010

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.0 Nursing contact hour

Pharmacists: 1.0 contact hour (0.1 CEUs)

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe current epidemiology of methamphetamine abuse in HIV-infected patients
Detail the common effects of methamphetamine in HIV-infected individuals
Associate behaviors related to methamphetamine use with HIV-related transmission risk
Describe clinically relevant drug-drug interactions between methamphetamine and antiretrovirals
Identify practical interventions that can be used in HIV care settings to address methamphetamine use and addiction

Topics covered include:

Introduction
Epidemiology of Methamphetamine Use and Abuse
Acute and Chronic Effects of Methamphetamine Use
Methamphetamine Use in HIV-Infected Individuals: Potential Functional Attributes in Gay and Bisexual Men
Methamphetamine Use in HIV-Infected Individuals: Interactions With HIV Medications
Methamphetamine Use in Gay and Bisexual Men Living With HIV
Distinguishing Methamphetamine Use From Abuse and Dependence
Practical Clinical Interventions for Methamphetamine Use in HIV-Infected Patients
Concluding Remarks From the Author
Summary—Implications for Clinical Practice

Abstract

Click here to view abstract

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.